Equity Holders Agreement Sample Contracts

EQUITY HOLDERS’ AGREEMENT
Equity Holders’ Agreement • October 1st, 2021 • LianBio • Pharmaceutical preparations

This EQUITY HOLDERS’ AGREEMENT (this “Agreement”) is made as of August 10, 2020 (the “Effective Date”), by and among LianBio, an exempted company organized under the laws of the Cayman Islands (the “Parent” or “LianBio”), LianBio Cardiovascular, an exempted company organized under the laws of the Cayman Islands and a wholly-owned subsidiary of the Parent, (the “Company”) and MyoKardia, Inc., a corporation organized and existing under the laws of the State of Delaware (“MyoKardia”, together with the Parent, the “Equity Holders”, and individually, a “Equity Holder”).

AutoNDA by SimpleDocs
RECITALS:
Equity Holders Agreement • August 27th, 1997 • Dental Care Alliance Inc • Delaware
HEDGEPATH PHARMACEUTICALS, INC. AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENT Dated As of May 15, 2015
Equity Holders’ Agreement • August 14th, 2015 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware

This AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENT (this “Agreement”) is made and entered into as of the 15th day of May, 2015 (the “Effective Date”) by and among:

EQUITY HOLDERS AGREEMENT Dated as of August 21, 2008
Equity Holders Agreement • August 21st, 2008 • Evercore Partners Inc. • Investment advice • New York

THIS EQUITY HOLDERS AGREEMENT (this “Agreement”) is made and entered into as of August 21, 2008, by and between Evercore Partners Inc., a Delaware corporation (the “Company”), and Mizuho Corporate Bank, Ltd., a Japanese corporation (“Mizuho CB” or the “Investor”).

AMENDMENT NO. 1 TO AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENT
Equity Holders’ Agreement • December 22nd, 2015 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENT (the “Amendment”), dated effective as of December 17, 2015 (the “Effective Date”), is by and among:

EQUITY HOLDERS’ AGREEMENT
Equity Holders’ Agreement • October 28th, 2011 • FX Alliance Inc. • Security & commodity brokers, dealers, exchanges & services • Delaware

This Equity Holders’ Agreement (this “Agreement”) is made and entered into as of September 29 2006, by and among FX Alliance Inc., a Delaware corporation (the “Company”), the holders of Common Stock of the Company (the “Common Stock”) now or hereafter listed on Schedule A hereto (the “Common Holders”), and the holders of Series A Preferred Stock of the Company listed on Schedule B hereto (each of which is referred to herein as an “Investor” and collectively as the “Investors”). The Company, the Common Holders and the Investors are individually referred to herein as a “Party” and are collectively referred to herein as the “Parties.” The Company’s Board of Directors is referred to herein as the “Board.”

Confidential Treatment Requested by HedgePath Pharmaceuticals, Inc., IRS Employer Identification No. 30-0793665 Confidential treatment requested with respect to certain portions hereof denoted with “***” HEDGEPATH PHARMACEUTICALS, INC. EQUITY HOLDERS...
Equity Holders Agreement • June 30th, 2014 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware

This EQUITY HOLDERS AGREEMENT (this “Agreement”) is made and entered into as of the 24th day of June, 2014 (the “Effective Date”) by and among:

RECITALS:
Equity Holders Agreement • August 27th, 1997 • Dental Care Alliance Inc • Delaware
Time is Money Join Law Insider Premium to draft better contracts faster.